Development and characterization of pepducins as Gs-biased allosteric agonists. - Wikidata - awgldk - TriplyDB

Development and characterization of pepducins as Gs-biased allosteric agonists.

Development and characterization of pepducins as Gs-biased allosteric agonists.

http://www.wikidata.org/entity/Q34774416

about

Data on human neutrophil activation induced by pepducins with amino acid sequences derived from β2AR and CXCR4 Minireview: Spatial Programming of G Protein-Coupled Receptor Activity: Decoding Signaling in Health and Disease Pleiotropic Effects of Bitter Taste Receptors on [Ca2+]i Mobilization, Hyperpolarization, and Relaxation of Human Airway Smooth Muscle Cells.Dysregulated Inflammatory Signaling upon Charcot-Marie-Tooth Type 1C Mutation of SIMPLE Protein.Allosteric Activation of a G Protein-coupled Receptor with Cell-penetrating Receptor Mimetics Specificity of arrestin subtypes in regulating airway smooth muscle G protein-coupled receptor signaling and function.Interdicting Gq Activation in Airway Disease by Receptor-Dependent and Receptor-Independent Mechanisms.β-arrestin-biased signaling through the β2-adrenergic receptor promotes cardiomyocyte contraction.Evidence for biased agonists and antagonists at the endothelin receptors Formyl Peptide Receptors in Mice and Men: Similarities and Differences in Recognition of Conventional Ligands and Modulating Lipopeptides.Pepducins and Other Lipidated Peptides as Mechanistic Probes and Therapeutics.Formyl peptide derived lipopeptides disclose differences between the receptors in mouse and men and call the pepducin concept in question Biased signaling of the proton-sensing receptor OGR1 by benzodiazepines.A synthetic intrabody-based selective and generic inhibitor of GPCR endocytosis.GPCR Retreat 2014: a good view leads to many discoveries!Prediction of consensus binding mode geometries for related chemical series of positive allosteric modulators of adenosine and muscarinic acetylcholine receptors.Pepducin-mediated cardioprotection via β-arrestin-biased β2-adrenergic receptor-specific signaling Designer Approaches for G Protein-Coupled Receptor Modulation for Cardiovascular Disease

P2860

Q31111760-0B85C334-4E16-4E13-BE8F-A51D6D54D03B Q33631599-252D7B98-CB64-418A-8B5A-82A3475ADD6B Q35677528-D723E201-B037-42B0-BDDC-DC386D939A15 Q35764200-F7226132-A6D5-4347-BBA0-908BFBA64053 Q35860717-2E3A0240-127D-402E-82AD-3FA018A2E998 Q36051502-60275975-BBC5-4519-827F-4AA46A626AEB Q36432415-5249B8B0-D4FC-421F-8EA6-D09CAB6395A7 Q37102508-7C013541-BC14-46A8-A359-87DAECC8BC1E Q38742466-A33B0366-20E5-45B6-99BD-B2A35699D4BB Q40062624-A9DC49C7-4A28-49D4-8755-1D4FBB9F7042 Q40405065-F7E39A4E-16E6-4519-9418-2CE1861E293A Q42362132-9F48D138-BA70-4F24-B709-9CE14E1D3A3C Q47435365-EB40607F-E752-430B-A2BD-1FBB743F1939 Q47716701-9A845B16-46E8-4E46-8579-8DBE14C39E80 Q51288462-DF24D181-D004-4704-9A5D-6A70E39B1BF1 Q52737158-9F96EE4B-FB79-4DD7-8E04-99E8CC77353E Q57116150-DFABF288-7B95-44F7-AD25-93187D17498C Q58698789-17D2E2F7-3CCA-456D-B02F-2E2099A437B9

P2860

Development and characterization of pepducins as Gs-biased allosteric agonists.

http://www.wikidata.org/entity/Q34774416

description

2014 nî lūn-bûn

@nan

2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Development and characterization of pepducins as Gs-biased allosteric agonists.

@ast

Development and characterization of pepducins as Gs-biased allosteric agonists.

@en

Development and characterization of pepducins as Gs-biased allosteric agonists.

@nl

type

label

Development and characterization of pepducins as Gs-biased allosteric agonists.

@ast

Development and characterization of pepducins as Gs-biased allosteric agonists.

@en

Development and characterization of pepducins as Gs-biased allosteric agonists.

@nl

prefLabel

Development and characterization of pepducins as Gs-biased allosteric agonists.

@ast

Development and characterization of pepducins as Gs-biased allosteric agonists.

@en

Development and characterization of pepducins as Gs-biased allosteric agonists.

@nl

P1433

Q34774416-328B1017-DEDE-46E1-99C2-B572E5DFC82E

P1476

Q34774416-F156D30F-44CC-42E2-BFFE-AE7E1E459FA0

P2093

Q34774416-4682F04E-52A9-478E-957B-BAD49FB94469

Q34774416-48E8F0D0-D60B-47C4-AFDA-9D6A2630AEAD

Q34774416-BA5A66EE-90E1-4817-A18C-04F1D0D601D7

Q34774416-D5B6617E-1040-476D-BB1A-2E149A97A6C8

Q34774416-DDF05553-353D-4E7D-97F9-3FCF62EF5F26

Q34774416-E0044962-1686-4A35-979E-99EAE5180D89

P2860

Q34774416-0C4879DB-32A4-4078-AAF9-DA40D4AE3BD9

Q34774416-0CA1BC73-A4F7-4123-A2C3-F603247BDE9F

Q34774416-0DDF480B-A36D-47FA-97D0-EDCAA23B1480

Q34774416-0EAA14B7-4190-4EB6-9A78-88B1B1675841

Q34774416-0FBC4BAF-8787-4EEB-9A4D-85A0CD4FB58F

Q34774416-18492666-96EB-4A55-B843-48E3C926D7E5

Q34774416-255BDDB7-C2A5-450C-BBA6-4C72291676DE

Q34774416-30F69F9F-7FDD-4782-AC20-E52D1C9D89A3

Q34774416-327B5B52-BFC9-4274-8517-738836BFC6C8

Q34774416-35CA37C1-63DF-42C5-A260-B7FFDB49A8A5

P304

Q34774416-B4A05415-D306-45E0-B83D-8E801B66573B

P31

Q34774416-26CFA3A0-F3C0-40F4-AB7F-8A94531EB7A5

P356

Q34774416-D236D258-31B3-4CF1-B16E-112B227E3073

P407

Q34774416-F86FB065-2547-4EE6-ADA6-47D55B46CC97

P433

Q34774416-B6C79F48-965A-40BA-9C1B-3B40EC86ECAC

P478

Q34774416-4BDA6A27-3E7D-44D3-A3EB-A94EC40984D4

P50

Q34774416-EE17552E-E092-47DF-A015-05BAFA607EFC

Q34774416-FC41F5C6-673D-46D9-969A-58E2D0C49B20

P577

Q34774416-B66CEA0E-772F-49C1-86D6-0682C6BCBCE3

P698

Q34774416-05325EBB-6C81-4676-895D-E0A73513411D

P921

Q34774416-FC9A3D15-4360-4053-A6B0-2AE39C6D8C76

P932

Q34774416-78F29999-D892-4CCC-B93F-DF4205FABE1D

P356

JBC.M114.618819

P1433

Journal of Biological Chemistry

P1476

Development and characterization of pepducins as Gs-biased allosteric agonists.

@en

P2093

Jay M Janz

http://www.w3.org/2001/XMLSchema#string

Jeffrey L Benovic

http://www.w3.org/2001/XMLSchema#string

Julie Quoyer

http://www.w3.org/2001/XMLSchema#string

Reynold A Panettieri

http://www.w3.org/2001/XMLSchema#string

Richard Carr

http://www.w3.org/2001/XMLSchema#string

Yang Du

http://www.w3.org/2001/XMLSchema#string

P2860

beta-Arrestin: a protein that regulates beta-adrenergic receptor function

Activation and inhibition of G protein-coupled receptors by cell-penetrating membrane-tethered peptides

Structure of a nanobody-stabilized active state of the β(2) adrenoceptor

β(2) -adrenoceptor agonists: current and future direction

Crystal structure of the β2 adrenergic receptor-Gs protein complex

High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor

Contemporary use of β-blockers: clinical relevance of subclassification

Turning receptors on and off with intracellular pepducins: new insights into G-protein-coupled receptor drug development

Crystal structure of the human beta2 adrenergic G-protein-coupled receptor

GPCR engineering yields high-resolution structural insights into beta2-adrenergic receptor function

P304

35668-35684

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.M114.618819

http://www.w3.org/2001/XMLSchema#string

P407

P433

52

http://www.w3.org/2001/XMLSchema#string

P478

289

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-11-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25395624

http://www.w3.org/2001/XMLSchema#string

P921

P932

4276837

http://www.w3.org/2001/XMLSchema#string